Mirae Asset Global Investments Co. Ltd. Has $8.15 Million Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Mirae Asset Global Investments Co. Ltd. trimmed its holdings in Doximity, Inc. (NASDAQ:DOCSGet Rating) by 12.9% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 156,442 shares of the company’s stock after selling 23,153 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Doximity were worth $8,149,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in DOCS. Central Bank & Trust Co. raised its holdings in shares of Doximity by 400.0% in the first quarter. Central Bank & Trust Co. now owns 500 shares of the company’s stock valued at $26,000 after buying an additional 400 shares during the last quarter. Washington Trust Advisors Inc. bought a new position in shares of Doximity in the first quarter valued at about $28,000. Signaturefd LLC raised its holdings in Doximity by 460.0% during the 1st quarter. Signaturefd LLC now owns 728 shares of the company’s stock worth $38,000 after purchasing an additional 598 shares during the last quarter. New York State Common Retirement Fund bought a new stake in Doximity during the 1st quarter worth about $45,000. Finally, Your Advocates Ltd. LLP bought a new stake in Doximity during the 1st quarter worth about $47,000. 46.99% of the stock is owned by institutional investors.

Doximity Stock Performance

Shares of DOCS opened at $31.03 on Thursday. The stock has a 50 day simple moving average of $36.81 and a 200 day simple moving average of $39.94. Doximity, Inc. has a 52-week low of $27.06 and a 52-week high of $91.25. The firm has a market capitalization of $6.00 billion, a PE ratio of 44.33, a P/E/G ratio of 15.72 and a beta of 0.95.

Doximity (NASDAQ:DOCSGet Rating) last issued its quarterly earnings data on Thursday, August 4th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.03. Doximity had a return on equity of 17.99% and a net margin of 41.72%. The business had revenue of $90.64 million during the quarter, compared to analyst estimates of $89.34 million. Equities research analysts predict that Doximity, Inc. will post 0.54 EPS for the current fiscal year.

Analyst Ratings Changes

DOCS has been the subject of several recent research reports. KeyCorp initiated coverage on Doximity in a report on Thursday, September 15th. They set a “sector weight” rating for the company. Truist Financial initiated coverage on Doximity in a report on Wednesday, September 7th. They set a “hold” rating and a $35.00 price objective for the company. Bank of America cut Doximity from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $43.00 to $29.00 in a report on Friday, August 5th. Piper Sandler dropped their price objective on Doximity from $44.00 to $39.00 in a report on Friday, August 5th. Finally, Berenberg Bank reissued an “initiates” rating on shares of Doximity in a report on Friday, July 29th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $47.63.

Doximity Company Profile

(Get Rating)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Read More

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSGet Rating).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.